SCHEMBL7884616

SCHEMBL7884616

O=C(O)N(Cc1ccccc1)n1nc(Cc2ccc(F)cc2)c2ccccc2c1=O

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.52
ADRA1A P35348 3/20 0.46
HRH1 P35367 3/20 0.46
ADRA1B P35368 3/20 0.46
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.44
USP2 O75604 1/20 0.44
LMNA P02545 1/20 0.44
GLA P06280 1/20 0.42
MAPT P10636 1/20 0.41
ENPP1 P22413 1/20 0.40
TACR1 P25103 1/20 0.40
HRH3 Q9Y5N1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10700249 0.76 ADRA1A (0.57) TSHRADRA1AHRH1ADRA1BCYP1A2
SCHEMBL10482471 0.74 ADRA1A (0.61) TSHRADRA1AHRH1ADRA1BCYP1A2
SCHEMBL7894969 0.73 TSHR (0.66) TSHRADRA1AHRH1ADRA1BCYP1A2
SCHEMBL10700300 0.69 ADRA1A (0.55) TSHRADRA1AHRH1ADRA1BCYP1A2
SCHEMBL10700164 0.68 ADRA1A (0.55) TSHRADRA1AHRH1ADRA1BCYP1A2
SCHEMBL10698694 0.68 ADRA1A (0.62) TSHRADRA1AHRH1ADRA1BSMN1; SMN2
SCHEMBL9570448 0.67 TSHR (0.62) TSHRCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL1787363 0.67 TSHR (0.61) TSHRADRA1AHRH1ADRA1BCYP1A2
SCHEMBL8556390 0.67 ENPP1 (0.65) TSHRADRA1AHRH1ADRA1BCYP1A2
SCHEMBL15478270 0.66 TSHR (0.82) TSHRADRA1AHRH1ADRA1BCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6180629-B1 INDUCING OR PROMOTING APOPTOSIS AND FOR ARRESTING UNCONTROLLED NEOPLASTIC CELL PROLIFERATION, INCLUDING PRECANCEROUS AND CANCEROUS LESIONS CELL PATHWAYS, INC. 2001-01-30 US disclosed